256 related articles for article (PubMed ID: 10049825)
1. Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.
Lipinski KS; Fax P; Wilker B; Hennemann H; Brockmann D; Esche H
Virology; 1999 Mar; 255(1):94-105. PubMed ID: 10049825
[TBL] [Abstract][Full Text] [Related]
2. The E1A N terminus (aa 1-29) of the highly oncogenic adenovirus type 12 harbours a trans-activation function not detectable in the non-oncogenic serotype 2.
Lipinski KS; Kröner-Lux G; Esche H; Brockmann D
J Gen Virol; 1997 Feb; 78 ( Pt 2)():413-21. PubMed ID: 9018064
[TBL] [Abstract][Full Text] [Related]
3. The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.
Dorsman JC; Teunisse AF; Zantema A; van der Eb AJ
J Gen Virol; 1997 Feb; 78 ( Pt 2)():423-6. PubMed ID: 9018065
[TBL] [Abstract][Full Text] [Related]
4. Identification of specific amino acid residues of adenovirus 12 E1A involved in transformation and p300 binding.
Sawada Y; Ishino M; Miura K; Ohtsuka E; Fujinaga K
Virus Genes; 1997; 15(2):161-70. PubMed ID: 9421880
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation.
Boyd JM; Loewenstein PM; Tang Qq QQ; Yu L; Green M
J Virol; 2002 Feb; 76(3):1461-74. PubMed ID: 11773419
[TBL] [Abstract][Full Text] [Related]
6. The E1A proteins of all six human adenovirus subgroups target the p300/CBP acetyltransferases and the SAGA transcriptional regulatory complex.
Shuen M; Avvakumov N; Torchia J; Mymryk JS
Virology; 2003 Nov; 316(1):75-83. PubMed ID: 14599792
[TBL] [Abstract][Full Text] [Related]
7. E1A12S-mediated activation of the adenovirus type 12 E2 promoter depends on the histone acetyltransferase activity of p300/CBP.
Fax P; Lehmkuhler O; Kuhn C; Esche H; Brockmann D
J Biol Chem; 2000 Dec; 275(51):40554-60. PubMed ID: 11006273
[TBL] [Abstract][Full Text] [Related]
8. The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300.
Wang HG; Yaciuk P; Ricciardi RP; Green M; Yokoyama K; Moran E
J Virol; 1993 Aug; 67(8):4804-13. PubMed ID: 8331729
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.
O'Connor MJ; Zimmermann H; Nielsen S; Bernard HU; Kouzarides T
J Virol; 1999 May; 73(5):3574-81. PubMed ID: 10196247
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP.
Lundblad JR; Kwok RP; Laurance ME; Harter ML; Goodman RH
Nature; 1995 Mar; 374(6517):85-8. PubMed ID: 7870179
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional co-activator proteins p300 and CBP stimulate adenovirus E1A conserved region 1 transactivation independent of a direct interaction.
Mannervik M; Akusjärvi G
FEBS Lett; 1997 Sep; 414(1):111-6. PubMed ID: 9305742
[TBL] [Abstract][Full Text] [Related]
12. A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.
Vries RG; Prudenziati M; Zwartjes C; Verlaan M; Kalkhoven E; Zantema A
EMBO J; 2001 Nov; 20(21):6095-103. PubMed ID: 11689449
[TBL] [Abstract][Full Text] [Related]
13. A point mutation in the first splice donor leads to reduced oncogenic properties of the adenovirus serotype 12 E1A gene.
Lehmkühler O; Kühn C; Gunawardena B; Esche H; Brockmann D
Intervirology; 2003; 46(1):1-16. PubMed ID: 12566694
[TBL] [Abstract][Full Text] [Related]
14. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
[TBL] [Abstract][Full Text] [Related]
15. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
Yang XJ; Ogryzko VV; Nishikawa J; Howard BH; Nakatani Y
Nature; 1996 Jul; 382(6589):319-24. PubMed ID: 8684459
[TBL] [Abstract][Full Text] [Related]
16. Caspase-mediated cleavage of adenovirus early region 1A proteins.
Grand RJ; Schmeiser K; Gordon EM; Zhang X; Gallimore PH; Turnell AS
Virology; 2002 Sep; 301(2):255-71. PubMed ID: 12359428
[TBL] [Abstract][Full Text] [Related]
17. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
Sandmöller A; Meents H; Arnold HH
Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
[TBL] [Abstract][Full Text] [Related]
18. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.
Albanese C; D'Amico M; Reutens AT; Fu M; Watanabe G; Lee RJ; Kitsis RN; Henglein B; Avantaggiati M; Somasundaram K; Thimmapaya B; Pestell RG
J Biol Chem; 1999 Nov; 274(48):34186-95. PubMed ID: 10567390
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A.
Jelinek T; Pereira DS; Graham FL
J Virol; 1994 Feb; 68(2):888-96. PubMed ID: 8289391
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus type 12 early region 1A expresses a 52R protein repressing the trans-activating activity of transcription factor c-Jun/AP-1.
Brockmann D; Feng L; Kröner G; Tries B; Esche H
Virology; 1994 Feb; 198(2):717-23. PubMed ID: 8291251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
